![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
P Chiba, G Ecker, D Schmid, J Drach, B Tell, S Goldenberg and V Gekeler
Department of Medical Chemistry, University of Vienna, Austria. peter.chiba@univie.ac.at
The sodium channel blocker propafenone and a series of analogs have been identified as effective modulators of P-glyco-protein-mediated multidrug resistance in human tumor cells. A series of closely related structural homologues showed a highly significant correlation between lipophilicity and pharmacological effect. Reduction of the carbonyl group as well as conversion to a methylether led to a remarkable decrease in activity, whereby lipophilicity lost its predictive character as the main determinant for modulator potency. Similarly, the relative positioning of the acyl- and propanolamine side chains also influences activity, so the distance between carbonyl group and nitrogen atom seems important.
This article has been cited by other articles:
|
|
 |
|
  D. Schmid, D. L. Staudacher, H. G. Loew, P. G. Spieckermann, G. F. Ecker, S. Kopp, and P. Chiba A Subset of Highly Effective Propafenone-Type Multidrug Resistance Modulators Lacks Effects on Cardiac Action Potential and Mechanical Twitch Parameters of Rat Papillary Muscles J. Pharmacol. Exp. Ther., November 1, 2003; 307(2): 589 - 596. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ekins, R. B. Kim, B. F. Leake, A. H. Dantzig, E. G. Schuetz, L.-B. Lan, K. Yasuda, R. L. Shepard, M. A. Winter, J. D. Schuetz, et al. Three-Dimensional Quantitative Structure-Activity Relationships of Inhibitors of P-Glycoprotein Mol. Pharmacol., May 1, 2002; 61(5): 964 - 973. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. F. Ecker, E. Csaszar, S. Kopp, B. Plagens, W. Holzer, W. Ernst, and P. Chiba Identification of Ligand-Binding Regions of P-Glycoprotein by Activated-Pharmacophore Photoaffinity Labeling and Matrix-Assisted Laser Desorption/Ionization-Time-of-Flight Mass Spectrometry Mol. Pharmacol., March 1, 2002; 61(3): 637 - 648. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Vigano, M. Julien, I. Carrier, P. Gros, and J.-M. Ruysschaert Structural and Functional Asymmetry of the Nucleotide-binding Domains of P-glycoprotein Investigated by Attenuated Total Reflection Fourier Transform Infrared Spectroscopy J. Biol. Chem., February 8, 2002; 277(7): 5008 - 5016. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Martin, G. Berridge, C. F. Higgins, P. Mistry, P. Charlton, and R. Callaghan Communication between Multiple Drug Binding Sites on P-glycoprotein Mol. Pharmacol., September 1, 2000; 58(3): 624 - 632. [Abstract] [Full Text]
|
|
|
|
|
|
G. Ecker, M. Huber, D. Schmid, and P. Chiba The Importance of a Nitrogen Atom in Modulators of Multidrug Resistance Mol. Pharmacol., October 1, 1999; 56(4): 791 - 796. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
